Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study will asses epidemiologic changes in eyelash characteristics with increasing age.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Healthy Females | Healthy Females |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| No treatment | Other | No treatment will be provided |
|
| Measure | Description | Time Frame |
|---|---|---|
| Eyelash Length as Measured by Digital Image Analysis (DIA) | Photographs were taken of the eyelashes. Length was measured in millimeters. Data from both eyes were averaged for each participant for analysis. | Baseline |
| Measure | Description | Time Frame |
|---|---|---|
| Eyelash Thickness as Measured by Digital Image Analysis (DIA) | Photographs were taken of the eyelashes. Eyelash thickness/fullness was assessed across both eyes as an average of the 3 preset areas measured in millimeters squared (mm^2). | Baseline |
| Eyelash Darkness as Measured by Digital Image Analysis (DIA) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Healthy Females
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Medical Director | Allergan | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Irvine | California | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 25347452 | Background | Glaser DA, Jones D, Carruthers J, Campo A, Moench S, Tardie G, Largent J, Caulkins C. Epidemiologic analysis of change in eyelash characteristics with increasing age in a population of healthy women. Dermatol Surg. 2014 Nov;40(11):1208-13. doi: 10.1097/DSS.0000000000000170. |
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Healthy Females | Participant's eyelashes were photographed at one study visit. |
| Title | Milestones | Reasons Not Completed | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Healthy Females | Participant's eyelashes were photographed at one study visit. |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Continuous | Mean |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Eyelash Length as Measured by Digital Image Analysis (DIA) | Photographs were taken of the eyelashes. Length was measured in millimeters. Data from both eyes were averaged for each participant for analysis. | All participants with values available. | Posted | Mean | Full Range | Millimeters (mm) | Baseline |
|
|
Not provided
Adverse events were not collected.
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Healthy Females | Healthy Females |
Not provided
Not provided
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Vice President Medical Affairs, | Allergan, Inc | 714-246-4500 | clinicaltrials@allergan.com |
Not provided
Not provided
Not provided
Not provided
Photographs were taken of the Eyelashes. Eyelash darkness (intensity) was measured within the spline (a narrow area approximately 5 pixels wide that bisects the area of interest). Eyelash darkness was measured in both eyes and averaged for analysis using a scale where 0=black and 255=white. |
| Baseline |
| Years |
|
| Sex: Female, Male | Count of Participants | Participants |
|
|
| Secondary | Eyelash Thickness as Measured by Digital Image Analysis (DIA) | Photographs were taken of the eyelashes. Eyelash thickness/fullness was assessed across both eyes as an average of the 3 preset areas measured in millimeters squared (mm^2). | All participants with values available. | Posted | Mean | Full Range | Millimeters squared (mm^2) | Baseline |
|
|
|
| Secondary | Eyelash Darkness as Measured by Digital Image Analysis (DIA) | Photographs were taken of the Eyelashes. Eyelash darkness (intensity) was measured within the spline (a narrow area approximately 5 pixels wide that bisects the area of interest). Eyelash darkness was measured in both eyes and averaged for analysis using a scale where 0=black and 255=white. | All participants with values available. | Posted | Mean | Full Range | Units on a scale | Baseline |
|
|
|
| 0 |
| 0 |
| 0 |
| 0 |
A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.